Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Ertugliflozin on Kidney Outcomes in Patients With Heart Failure at Baseline in the Evaluation of Ertugliflozin Efficacy and Safety Cardiovascular Outcomes (VERTIS CV) Trial.
Cherney DZI, Cosentino F, McGuire DK, Kolkailah AA, Dagogo-Jack S, Pratley RE, Frederich R, Maldonado M, Liu CC, Cannon CP; VERTIS CV Investigators. Cherney DZI, et al. Among authors: mcguire dk. Kidney Int Rep. 2023 Jan 20;8(4):746-753. doi: 10.1016/j.ekir.2023.01.011. eCollection 2023 Apr. Kidney Int Rep. 2023. PMID: 37069970 Free PMC article.
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.
Nuffield Department of Population Health Renal Studies Group; SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. Nuffield Department of Population Health Renal Studies Group, et al. Lancet. 2022 Nov 19;400(10365):1788-1801. doi: 10.1016/S0140-6736(22)02074-8. Epub 2022 Nov 6. Lancet. 2022. PMID: 36351458 Free PMC article.
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Kim JM, Bhatt DL, Dagogo-Jack S, Cherney DZI, Cosentino F, McGuire DK, Pratley RE, Liu CC, Cater NB, Frederich R, Mancuso JP, Cannon CP. Kim JM, et al. Among authors: mcguire dk. Diabetes Obes Metab. 2023 May;25(5):1398-1402. doi: 10.1111/dom.14965. Epub 2023 Feb 14. Diabetes Obes Metab. 2023. PMID: 36594154 No abstract available.
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study.
Rawshani A, Eliasson B, Boren J, Sattar N, Bhatt D, El-Khalili L, Nordanstig J, Avdic T, Beckman JA, Gerstein HC, McGuire DK, Omerovic E, Rawshani A. Rawshani A, et al. Among authors: mcguire dk. Lancet Reg Health Eur. 2024 Mar 19;39:100888. doi: 10.1016/j.lanepe.2024.100888. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38803635 Free PMC article.
Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study.
Avdic T, Eliasson B, Rawshani A, Boren J, Gerstein HC, Nordanstig J, Rihawi M, Beckman JA, McGuire DK, Omerovic E, Sattar N, Bhatt DL, Rawshani A. Avdic T, et al. Among authors: mcguire dk. Lancet Reg Health Eur. 2024 Feb 15;39:100852. doi: 10.1016/j.lanepe.2024.100852. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38803631 Free PMC article.
What the SELECT trial of semaglutide means for clinicians.
Sattar N, Lee MMY, McGuire DK. Sattar N, et al. Among authors: mcguire dk. Nat Med. 2024 May 25. doi: 10.1038/s41591-024-03013-7. Online ahead of print. Nat Med. 2024. PMID: 38796654 No abstract available.
Obesity and Cardiovascular Disease: A New Dawn.
Sattar N, Neeland IJ, McGuire DK. Sattar N, et al. Among authors: mcguire dk. Circulation. 2024 May 21;149(21):1621-1623. doi: 10.1161/CIRCULATIONAHA.123.065485. Epub 2024 May 20. Circulation. 2024. PMID: 38768272 Free article. Review. No abstract available.
475 results